Amphastar Pharmaceuticals, Inc. - 8-K Filing
Amphastar Pharmaceuticals held its annual stockholder meeting on June 1, 2026, where shareholders voted to elect three Class I directors (David Gaugh, William J. Peters, Jacob Liawatidewi), ratified the appointment of Ernst & Young LLP as auditors for fiscal year ending December 31, 2026, approved executive compensation on an advisory basis, and set annual frequency for future advisory votes on executive pay through at least 2032. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $AMPH